(Q40689809)

22 September 2017

title

Patterns of patient enrollment in randomized controlled trials (English)

1 reference

22 September 2017

1 reference

2

Ioannidis JP

1 reference

22 September 2017

Haidich AB

1

1 reference

22 September 2017

publication date

1 September 2001

1 reference

Journal of Clinical Epidemiology

22 September 2017

published in

1 reference

22 September 2017

volume

54

1 reference

22 September 2017

issue

9

1 reference

22 September 2017

page(s)

877-883

1 reference

Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900353-5

7 January 2021

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900353-5

7 January 2021

A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900353-5

7 January 2021

A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900353-5

7 January 2021

Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900353-5

7 January 2021

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900353-5

7 January 2021

The futility index. An approach to the cost-effective termination of randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900353-5

7 January 2021

Using economic analysis to determine the resource consequences of choices made in planning clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900353-5

7 January 2021

Using cost-effectiveness analysis to improve the efficiency of allocating funds to clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900353-5

7 January 2021

When to stop a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900353-5

7 January 2021

Changes in clinical trials mandated by the advent of meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900353-5

7 January 2021

The Rational Use of Therapeutic Drugs in the 21st Century:Important Lessons from Cumulative Meta-analyses of Randomized Control Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900353-5

7 January 2021

Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900353-5

7 January 2021

Impact of epidemic and individual heterogeneity on the population distribution of disease progression rates. An example from patient populations in trials of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900353-5

7 January 2021

Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithm

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2801%2900353-5

7 January 2021

10.1016/S0895-4356(01)00353-5

Identifiers

DOI

1 reference

22 September 2017

1 reference